The pharmacokinetics of ceftriaxone were studied for seven patients with pleural effusion of various etiologies. All patients received 1 g of antibiotic, administered as an intravenous bolus. The pleural fluid had a high total protein content (6.0 g/dl). Ceftriaxone levels in plasma and in pleural fluid were determined by the agar well diffusion technique. Total and free drug concentrations in pleural fluid reached 7 to 8.7 and 3.8 to 2.3 ,ug/ml, respectively, in 4 to 6 h. The disappearance of the drug from the pleural fluid was very slow. In these patients, therapeutic ceftriaxone levels were present for at least 53 h in pleural fluid.
The pharmacokinetics of ceftriaxone were studied for seven patients with pleural effusion of various etiologies. All patients received 1 g of antibiotic, administered as an intravenous bolus. The pleural fluid had a high total protein content (6.0 g/dl). Ceftriaxone levels in plasma and in pleural fluid were determined by the agar well diffusion technique. Total and free drug concentrations in pleural fluid reached 7 to 8.7 and 3.8 to 2.3 ,ug/ml, respectively, in 4 to 6 h. The disappearance of the drug from the pleural fluid was very slow. In these patients, therapeutic ceftriaxone levels were present for at least 53 h in pleural fluid.
Although there have been numerous studies on the pharmacokinetics of ceftriaxone, little attention has been given to the penetration of this drug in pleural fluid. The determination of the levels reached by antibiotics in this fluid is of great interest because of the high number of secondary pleural effusions resulting from pulmonary infections (2, 3) and is therefore a determining factor in the treatment of infectious processes localized at this site. Under normal conditions, the protein content of the pleural fluid ranges between 13.8 and 33.5 g/liter (10), but these values can increase in pathological conditions. The aim of the present work was to establish values for the penetration and persistence of ceftriaxone, an antibiotic with high protein binding, in pleural fluid after the administration of a 1-g dose intravenously.
was obtained from each patient. Venous blood and pleural fluid were obtained at different times after the drug administration. All samples were centrifuged, and serum and pleural fluid supernatants were stored at -20°C until they were assayed. The amount of blood contaminating the pleural fluid samples was assessed by measuring the hematocrit, which was always less than 10%. 
RESULTS
The clinical characteristics of patients included in the study are shown in Table 1 . The intravenous administration of ceftriaxone was well tolerated without any clinical adverse effects. The concentrations of total ceftriaxone in serum (in micrograms per milliliter) were 100 to 22 at 1 h, 34 to 50 at 4 h, 11 to 30 at 8 h, 6.8 to 21 at 24 h, and 4.0 to 4.3 at 53 h. Total drug concentrations in pleural fluid reached values of 7 to 8.7 ,ug/ml in 4 to 6 h and decreased to about 5.5 p.g/ml at 24 h and to about 5.0 ,ug/ml at 53 h ( Table 2 ). The Table 2) .
The free ceftriaxone concentrations in pleural fluid and serum are shown in Table 3 . The maximum pleural fluid levels of 3.8 to 2.3 pLg/ml were reached in 4 to 6 h. At 24 h, levels from 1.8 to 2.2 ,ug/ml were present in pleural fluid. In two patients, a free ceftriaxone concentration of 1.7 ,ug/ml was observed after 53 h. a function of time. This correlation, with a coefficient r of 0.83, confirmed the accessibility of the antibiotic to the pleural fluid. Its disappearance from this compartment was slower than from the systemic circulation.
DISCUSSION
The characterization of the pharmacokinetic profile of a drug from the values determined from its concentrations in plasma does not provide sufficient information regarding the diffusion of the drug in different organs and tissues. The patients with pleural effusion show the presence of a fluid which may be considered representative of interstitial tissue fluid (7) .
The characteristics of the pleural fluid from our patients suggested the presence of acute inflammation in the pleural space and high pleural protein content.
Ceftriaxone is a drug with high protein binding. It has been contended that this high serum binding inhibits the distribution of drug into tissue fluid (6, 9).
Gerding et al. (5) suggest that the appreciable binding of cephalosporins to ascitic fluid protein explains the high total concentrations of these drugs in ascitic fluid. Consequently, we measured binding to pleural fluid protein of ceftriaxone and found that the free-drug concentrations exceeded reported MICs for most susceptible organisms for at least 53 h (1) .
In this study, we found that the half-life of ceftriaxone in pleural fluid was about two to four times longer than in serum. Our data agree with the results reported by Gerding et al. (4), who reported that the half-lives of some cephalosporins in interstitial body fluid were 3.5 to 6.5 times those in serum.
The prolonged half-life of ceftriaxone in pleural fluid might be of great advantage for killing bacteria present in this space, because not only the concentration but also the time of antibiotic exposure is important for antibacterial activity.
